text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2024년 09월 30일\n)\n(단위 : 천원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n아피메즈(주)\n비상장\n2014.04.23\n신규사업진출\n2,090\n6,863,318\n22.5\n-\n-\n-\n-\n6,863,318\n22.5\n-\n2,866\n-2,254\n(주)프리텔레콤\n비상장\n2015.08.05\n신규사업진출\n14,300\n600,000\n100\n12,300\n-\n-\n-\n600,000\n100.0\n12,300\n33,064\n1,331\n(주)셀루메드\n상장\n2018.04.17\n신규사업진출\n16,000\n8,530,021\n20.4\n18,339\n5,359,057\n10,000\n12,703\n13,889,078\n28.8\n41,042\n75,931\n-6,303\n칼론인베스트먼트자산운용(주)\n비상장\n2019.02.26\n신규사업진출\n500\n50,000\n9.6\n500\n-\n-\n-\n50,000\n9.6\n500\n7,845\xa0\n490\xa0\n(주)파인파이어\n비상장\n2019.11.18\n신규사업진출\n1,050\n1,050,000\n45.5\n-\n-\n-\n-\n1,050,000\n45.5\n-\n300\n-141\n(주)빅바이오\n비상장\n2020.09.25\n신규사업진출\n4,999\n420,086\n39.0\n-\n-\n-\n-\n420,086\n39.0\n-\n950\n-279\nApimedsPharmaceuticalsUS, Inc.\n비상장\n2020.09.17\n신규사업진출\n296\n1,000\n17.9\n-\n-\n-\n-\n1,010\n37.2\n-\n47\n-866\n(주)달리는사람들\n비상장\n2022.07.22\n신규사업진출\n1,940\n308,084\n21.6\n1,488\n-\n-\n-98\n308,084\n21.6\n1,390\n924\n-452\n(주)스퍼리어인터내셔널\n비상장\n2022.08.18\n신규사업진출\n200\n200,001\n50.0\n200\n-\n-\n-\n200,001\n50.0\n200\n\xa0 \xa0353\n23\n나노실리콘(주)\n비상장\n2023.01.13\n신규사업진출\n1,500\n2,200,000\n27.5\n945\n-\n-\n541\n2,200,000\n22.4\n1,486\n7,843\n-1,663\n부산이디씨피에프브이㈜\n비상장\n2024.06.28\n신규사업진출\n1,000\n-\n-\n-\n50,000\n1,000\n-\n50,000\n10.0\n1,000\n4,875\n-127\n합 계\n20,222,520\n-\n33,772\n5,409,057\n11,000\n13,146\n25,631,577\n-\n57,918\n136,321\n-6,209\n주) 최근 사업연도 재무현황은 각 사의 2024년 3분기말 재무제표 기준입니다. 이는 외부감사인의 감사 또는 검토를 받지 않은 재무제표입니다.\n']"
